Lisa Ann Orloff, MD
Otolaryngology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Orloff’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G71176 · Current
Licensed to practise in California · since 1991 · expires 2027-03-31 · University of California, Los Angeles School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$67,161
Medicare paid this office $67,161 for 127 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal or exploration of parathyroid glands | 13 | $10,289 | $791 |
| New patient visit (60+ min) | 54 | $8,478 | $157 |
| Long return visit (40+ min) | 30 | $4,514 | $129 |
| Return visit (30+ min) | 31 | $2,870 | $82 |
| Ultrasound scan of head and neck soft tissue | 108 | $2,799 | $23 |
See all 8 services
| Removal or exploration of parathyroid glands | 13 | $10,289 | $791 |
| New patient visit (60+ min) | 54 | $8,478 | $157 |
| Long return visit (40+ min) | 30 | $4,514 | $129 |
| Return visit (30+ min) | 31 | $2,870 | $82 |
| Ultrasound scan of head and neck soft tissue | 108 | $2,799 | $23 |
| Exam to assess movement of vocal cord flaps using an endoscope | 18 | $2,055 | $108 |
| Ultrasonic guidance during surgery | 38 | $1,522 | $39 |
| Ultrasonic guidance for needle placement | 18 | $481 | $27 |
Who their Medicare patients are
127 Original Medicare patients in 2024. Average age 74 · Women 78% · Also on Medicaid 10% · Health risk score 1.03. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 61% · Coronary heart disease 23% · Diabetes 22% · Cancer 16% · Atrial fibrillation 14% · Chronic kidney disease 11% · Depression 10%.
The office billed $468,993, Medicare allowed $85,865 and paid $67,161; for 400 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 127 | 400 | 74 | 1.03 | $468,993 | $67,161 |
| 2023 | 137 | 447 | 73 | 1.12 | $454,522 | $72,194 |
| 2022 | 113 | 365 | 73 | 1.18 | $413,838 | $65,255 |
| 2021 | 113 | 349 | 73 | 1.46 | $364,717 | $64,926 |
| 2020 | 115 | 394 | 71 | 1.31 | $452,374 | $76,377 |
| 2019 | 115 | 398 | 72 | 1.27 | $373,701 | $67,962 |
| 2018 | 95 | 363 | 71 | 1.44 | $296,749 | $55,927 |
| 2017 | 102 | 358 | 71 | 1.32 | $322,293 | $61,401 |
| 2016 | 87 | 369 | 71 | 1.33 | $410,571 | $65,971 |
| 2015 | 88 | 358 | 74 | 1.26 | $376,672 | $61,355 |
| 2014 | 73 | 319 | 70 | 1.03 | $285,080 | $48,365 |
| 2013 | 98 | 438 | 71 | 1.33 | $413,542 | $65,127 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Removal or exploration of parathyroid glands | 13 | $11,580 | $891 |
| New patient visit (60+ min) | 66 | $10,622 | $161 |
| Long return visit (40+ min) | 36 | $5,273 | $129 |
| Ultrasound scan of head and neck soft tissue | 120 | $3,298 | $23 |
| Return visit (30+ min) | 29 | $2,584 | $83 |
| Exam to assess movement of vocal cord flaps using an endoscope | 19 | $1,820 | $91 |
| Ultrasonic guidance during surgery | 32 | $1,775 | $54 |
| Ultrasound guidance for tissue removal | 15 | $1,332 | $89 |
| Other procedure on nervous system | 13 | $976 | $75 |
| Ultrasonic guidance for needle placement | 18 | $499 | $28 |
2022: 7 services
| Removal or exploration of parathyroid glands | 13 | $11,535 | $887 |
| New patient visit (60+ min) | 48 | $7,301 | $152 |
| Long return visit (40+ min) | 31 | $4,100 | $121 |
| Return visit (30+ min) | 29 | $2,513 | $79 |
| Ultrasound scan of head and neck soft tissue | 98 | $2,486 | $22 |
| Ultrasonic guidance during surgery | 39 | $2,105 | $54 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 12 | $702 | $58 |
2021: 7 services
| Removal or exploration of parathyroid glands | 16 | $13,530 | $846 |
| New patient visit (60+ min) | 41 | $6,836 | $167 |
| Long return visit (40+ min) | 41 | $5,392 | $120 |
| Ultrasound scan of head and neck soft tissue | 94 | $2,441 | $23 |
| Ultrasonic guidance during surgery | 37 | $2,041 | $55 |
| Exam to assess movement of vocal cord flaps using an endoscope | 13 | $1,570 | $112 |
| Return visit (30+ min) | 14 | $1,358 | $91 |
2020: 6 services
| Removal or exploration of parathyroid glands | 13 | $11,601 | $892 |
| New patient visit (60+ min) | 58 | $9,112 | $157 |
| Long return visit (40+ min) | 48 | $6,031 | $101 |
| Ultrasound scan of head and neck soft tissue | 97 | $2,621 | $24 |
| Ultrasonic guidance during surgery | 40 | $2,244 | $56 |
| Exam to assess movement of vocal cord flaps using an endoscope | 20 | $1,644 | $78 |
2019: 5 services
| New patient visit (60+ min) | 49 | $7,272 | $148 |
| Long return visit (40+ min) | 57 | $6,720 | $100 |
| Exam to assess movement of vocal cord flaps using an endoscope | 55 | $6,503 | $107 |
| Ultrasound scan of head and neck soft tissue | 93 | $2,433 | $25 |
| Ultrasonic guidance during surgery | 37 | $1,993 | $54 |
2018: 7 services
| New patient visit (60+ min) | 43 | $6,444 | $150 |
| Exam to assess movement of vocal cord flaps using an endoscope | 54 | $5,523 | $97 |
| Long return visit (40+ min) | 42 | $4,970 | $96 |
| Ultrasound scan of head and neck soft tissue | 79 | $2,062 | $24 |
| Ultrasonic guidance during surgery | 25 | $1,350 | $54 |
| Fine needle aspiration using imaging guidance | 14 | $879 | $55 |
| Ultrasonic guidance for needle placement | 17 | $467 | $27 |
2017: 5 services
| New patient visit (60+ min) | 50 | $7,364 | $147 |
| Exam to assess movement of vocal cord flaps using an endoscope | 51 | $5,472 | $105 |
| Long return visit (40+ min) | 41 | $4,402 | $94 |
| Ultrasound scan of head and neck soft tissue | 84 | $2,086 | $24 |
| Ultrasonic guidance during surgery | 33 | $1,835 | $54 |
2016: 6 services
| Removal or exploration of parathyroid glands | 12 | $9,665 | $805 |
| Exam to assess movement of vocal cord flaps using an endoscope | 42 | $6,091 | $127 |
| New patient visit (60+ min) | 39 | $4,891 | $125 |
| Long return visit (40+ min) | 41 | $4,396 | $88 |
| Ultrasound scan of head and neck soft tissue | 75 | $1,966 | $24 |
| Ultrasonic guidance during surgery | 37 | $1,885 | $51 |
2015: 6 services
| Removal or exploration of parathyroid glands | 13 | $11,031 | $849 |
| New patient visit (60+ min) | 45 | $6,312 | $140 |
| Exam to assess movement of vocal cord flaps using an endoscope | 45 | $6,141 | $125 |
| Long return visit (40+ min) | 31 | $3,496 | $92 |
| Ultrasound scan of head and neck soft tissue | 78 | $2,120 | $24 |
| Ultrasonic guidance during surgery | 33 | $1,781 | $54 |
2014: 7 services
| New patient visit (60+ min) | 33 | $4,847 | $147 |
| Exam to assess movement of vocal cord flaps using an endoscope | 30 | $4,179 | $131 |
| Long return visit (40+ min) | 26 | $2,664 | $95 |
| Ultrasound scan of head and neck soft tissue | 64 | $1,909 | $25 |
| Return visit (30+ min) | 13 | $1,328 | $70 |
| Diagnostic exam of voice box using a flexible endoscope | 16 | $1,250 | $69 |
| Ultrasonic guidance during surgery | 21 | $1,144 | $54 |
2013: 9 services
| Removal or exploration of parathyroid glands | 12 | $9,016 | $751 |
| Exam to assess movement of vocal cord flaps using an endoscope | 40 | $5,707 | $130 |
| New patient visit (60+ min) | 32 | $4,524 | $141 |
| Return visit (30+ min) | 41 | $3,581 | $65 |
| Release and/or relocation of cranial nerve | 11 | $3,532 | $252 |
| Ultrasound scan of head and neck soft tissue | 88 | $3,346 | $24 |
| Long return visit (40+ min) | 13 | $1,327 | $83 |
| Ultrasonic guidance for needle placement | 19 | $869 | $29 |
| Fine needle aspiration using imaging guidance | 12 | $678 | $56 |
Money from drug and device companies
$220 in 2025
| 2025 | 1 | 2 | None | $220 |
| 2023 | 2 | 8 | $8,136 | $8,908 |
| 2022 | 1 | 2 | None | $65 |
| 2020 | 1 | 1 | None | $146 |
| 2019 | 1 | 3 | None | $129 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pulse Biosciences | Cellfx | $220 | 2 payments
|
See all 2 published payments
| Pulse Biosciences | Meals · 2025-08-21 | Cellfx | $85 |
| Pulse Biosciences | Meals · 2025-01-31 | Cellfx | $135 |
See earlier years (2023, 2022, 2020, 2019)
2023: $8,908
| Ascendis Pharma | None | $8,829 | 7 payments
|
| Medtronic | Nim Vital | $79 | 1 payment
|
2022: $65
| Medtronic | Mazor X System | $65 | 2 payments
|
2020: $146
| Intersect ENT | Sinuva | $146 | 1 payment
|
2019: $129
| Medtronic USA | Nim | $129 | 3 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1619934122
- Licence
- CA G71176California G71176: Current · expires 2027-03-31
- Trained
- University of California, Geffen School of Medicine, 1982
- Group
- Stanford Health Care
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 0G7117600
- Taxonomy
- Federal specialty code 207YX0905X (207YX0905X); Otolaryngology (207Y00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-04-27
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.